Skip to main content
Fig. 1 | Diabetology & Metabolic Syndrome

Fig. 1

From: The influence of dopamine-beta-hydroxylase and catechol O-methyltransferase gene polymorphism on the efficacy of insulin detemir therapy in patients with type 2 diabetes mellitus

Fig. 1

Changes in HbA1c, fasting plasma glucose values, and BMI due to 52-weeks of treatment. Central box represents the values from the lower to upper quartile and the middle line represents the median. The horizontal line extends from the minimum to the maximum value (non-outlier range) and the “far out” values (outliers) are displayed as separate points: a changes in HbA1c due to 52-week of treatment; b changes in fasting plasma glucose values due to 52-week of treatment; c changes in BMI due to 52-week of treatment. ***p < 0.001 vs. the baseline values

Back to article page